Proton Pump Inhibitors Therapy in Children with Gastroesophageal Reflux

Authors

  • Aldo Reynaldo
  • Badriul Hegar

DOI:

https://doi.org/10.24871/1432013158-164

Abstract

Proton pump inhibitors (PPI) has been widely used by clinicians to treat diseases that require suppression of gastric acid. PPI work by inhibiting the proton pump in gastric parietal cells.In adult patients, PPI has
been widely studied and showed effective results and safe. This result make PPI positioning as the first choice medicine in the treatment of diseases that require suppression of gastric acid. As the primary choice therapy, PPI administration has been increased not only in adults but also in children.

PPI is often administered to children with a diagnosis of gastroesophageal reflux disease (GERD) which defined as symptoms or complications caused by gastroesophageal reflux (GER). GERD diagnosis in children is quite difficult, so it is common to find that diagnosis is established only by the basis of clinical symptoms, resulting in overdiagnosis and over-treatment of GERD. The use of PPI in children still needs further study and
can not be inferred based on adult studies. Inappropropriate PPI prescription without indication will increase side effect, risk and also harm the children. Thus, it is important to know the indications, side effects and safety of PPI therapy in children.

Keywords: proton pump inhibitor, children, gastroesophageal reflux disease

Downloads

Published

2013-12-31

How to Cite

Reynaldo, A., & Hegar, B. (2013). Proton Pump Inhibitors Therapy in Children with Gastroesophageal Reflux. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 14(3), 158–164. https://doi.org/10.24871/1432013158-164

Issue

VOLUME 14, NUMBER 3, December 2013

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).